Related Experiment Video
Updated: Jun 10, 2026

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
Published on: March 28, 2025
Rapid Hemostasis and Antiadhesion Gauze Based on a Structured Hydrophobic Surface Engineered by an Inorganic LDH
Jianyang Shan1, Hui Hu2, Zhen Ding1,3
1Department of Orthopedic Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, National Center for Orthopaedic, Medicine, Shanghai 200233, P. R. China.
A novel hemostatic gauze, Gauze@LDH, effectively stops bleeding and prevents tissue adhesion. This advanced material offers improved biocompatibility and faster clotting times, addressing critical needs in trauma care.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Trauma Medicine
Background:
- Uncontrolled hemorrhage is a leading cause of trauma mortality.
- Conventional gauze has limitations in achieving rapid hemostasis and preventing tissue adhesion.
Purpose of the Study:
- To develop and evaluate Gauze@LDH, a novel hemostatic gauze engineered with layered double hydroxide nanosheets.
- To assess the hemostatic efficacy, biocompatibility, and anti-adhesion properties of Gauze@LDH.
Main Methods:
- Gauze modification using magnesium/aluminum layered double hydroxide nanosheets via hydrothermal synthesis.
- Evaluation of surface properties, blood absorption, clotting time, biocompatibility (hemolysis, cytotoxicity), and hemostatic performance in simulated and in vivo trauma models.
Main Results:
- Gauze@LDH demonstrated a shift from hydrophilic to hydrophobic, reducing blood absorption.
- Achieved rapid clotting in 1 minute, three times faster than conventional gauze.
- Showcased excellent biocompatibility with low hemolysis (0.209%) and minimal cytotoxicity.
- Significantly reduced blood loss in simulated vascular rupture models.
- Confirmed immediate hemostatic efficacy in vivo liver defect and tail-vein transection models.
- Prevented organ adhesions in a liver-penetrating injury model, unlike plain gauze.
Conclusions:
- Gauze@LDH integrates rapid hemostasis, biocompatibility, and anti-adhesion properties.
- This engineered gauze addresses key limitations of current hemostatic agents.
- Gauze@LDH presents a cost-effective solution for improving trauma care outcomes.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...

